Resveratrol suppresses vascular endothelial growth factor secretion via inhibition of CXC-chemokine receptor 4 expression in ARPE-19 cells

Molecular Medicine Reports

Volumn 12, Issue 1, 2015, Pages 1479-1484

  Seong, Hyemin ^a   Ryu, Jinhyun ^a   Jeong, Joo Yeon ^a   Chung, In Young ^a   Han, Yong Seop ^a   Hwang, Soo Hyun ^a   Park, Jong Moon ^a   Kang, Sang Soo ^a   Seo, Seong Wook ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

Author keywords

ARPE 19; CXC chemokine receptor 4; Hypoxia; Neovascularization; Resveratrol; Vascular endothelial growth factor

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN; COBALT; COBALT CHLORIDE; CXCL12 PROTEIN, HUMAN; HIF1A PROTEIN, HUMAN; STILBENE DERIVATIVE; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CELL HYPOXIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; IN VITRO STUDY; PROTEIN EXPRESSION; PROTEIN SECRETION; RETINA NEOVASCULARIZATION; RETINA PIGMENT CELL; SIGNAL TRANSDUCTION; UMBILICAL VEIN ENDOTHELIAL CELL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; BIOSYNTHESIS; CELL LINE; CELL PROLIFERATION; DRUG EFFECTS; ENDOTHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PIGMENT EPITHELIUM;

APOPTOSIS; CELL HYPOXIA; CELL LINE; CELL PROLIFERATION; CHEMOKINE CXCL12; COBALT; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; NF-KAPPA B; RECEPTORS, CXCR4; RETINAL PIGMENT EPITHELIUM; SIGNAL TRANSDUCTION; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84926673022     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2015.3518     Document Type: Article

References (37)

1. Neely KA and Gardner TW Ocular neovascularization clarifying complex interactions. Am J Pathol 153 665-670, 1998.
2. Chang JH, Garg NK, Lunde E, Han KY, Jain S and Azar DT Corneal neovascularization An anti-VEGF therapy review. Surv Opthalmol 57 415-429, 2012.
3. Chan EC, van Wijngaarden P, Liu GS, Jiang F, Peshavariya H and Dusting GJ Involvement of Nox2 NADPH oxidase in retinal neovascularization. Invest Ophthalmol Vis Sci 54 7061-7067, 2013.
4. Engelmann D, Mayoli-Nüssle D, Mayrhofer C, et al E2F1 promotes angiogenesis through the VEGF-C/VEGFR-3 axis in a feedback loop for cooperative induction of PDGF-B. J Mol Cell Biol 5 391-403, 2013.
5. Ma JF, Von Kalle M, Plautz Q, -M Xu F, Singh L and Wang L Relaxin promotes in vitro tumour growth, invasion and angiogenesis of human Saos-2 osteosarcoma cells by AKT/VEGF pathway. Eur Rev Med Pharmacol Sci 17 1345-1350, 2013.
6. Muller YA, Christinger HW, Keyt BA and de Vos AM The crystal structure of vascular endothelial growth factor (VEGF) refined to 1.93 A resolution multiple copy flexibility and receptor binding. Structure 5 1325-1338, 1997.
7. Ciulla TA, Danis RP, Criswell M and Pratt LM Changing therapeutic paradigms for exudative age-related macular degen-eration antiangiogenic agents and photodynamic therapy. Expert Opin Investig Drugs 8 2173-2182, 1999.
8. Cheng SF, Dastjerdi MH, Ferrari G, et al Short-term topical bevacizumab in the treatment of stable corneal neovascularization. Am J Ophthalmol 154 940-948, 2012.
9. Campochiaro PA Retinal and choroidal neovascularization. J Cell Physiol 184 301-310, 2000.
10. Liu XH, Kirschenbaum A, Yao S, et al Upregulation of vascular endothelial growth factor by cobalt chloride-simulated hypoxia is mediated by persistent induction of cyclooxygenase-2 in a metastatic human prostate cancer cell line. Clin Exp Metastasis 17 687-694, 1999.
11. Wang Y, Huang L, Yang Y, Xu L, Yang J and Wu Y Effects of autocrine vascular endothelial growth factor (VEGF) in non-small cell lung cancer cell line A549. Mol Biol Rep 40 3093-3099, 2013.
12. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE and D'Amore PA An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. Proc Natl Acad Sci USA 106 18751-18756, 2009.
13. Wei L, Fraser JL, Lu ZY, Hu X and Yu SP Transplantation of hypoxia preconditioned bone marrow mesenchymal stem cells enhances angiogenesis and neurogenesis after cerebral ischemia in rats. Neurobiol Dis 46 635-645, 2012.
14. Salcedo R, Wasserman K, Young HA, et al Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells In vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 154 1125-1135, 1999.
15. Jin F, Brockmeier U, Otterbach F and Metzen E New insight into the SDF-1/CXCR4 axis in a breast carcinoma model hypoxia-induced endothelial SDF-1 and tumor cell CXCR4 are required for tumor cell intravasation. Mol Cancer Res 10 1021-1031, 2012.
16. Ozcan Cenksoy P, Oktem M, Erdem O, et al A potential novel treatment strategy Inhibition of angiogenesis and inflammation by resveratrol for regression of endometriosis in an experimental rat model. Gynecol Endocrinol Nov 6, 2014 (Epub ahead of print).
17. Li C, Wang L, Huang K and Zheng L Endoplasmic reticulum strss in retinal vascular degeneration Protective role of resveratrol. Invest Opthalmol Vis Sci 53 3241-3249, 2012.
18. Jang M, Cai L, Udeani GO, et al Cancer chemopreventive activity of resveratrol, a natural product derived from grapes. Science 275 218-220, 1997.
19. de la Lastra CA and Villegas I Resveratrol as an antioxidant and pro-oxidant agent mechanisms and clinical implications. Biochem Soc Trans 35 1156-1160, 2007.
20. Soufi FG, Mohammad-Nejad D and Ahmadieh H Resveratrol improves diabetic retinopathy possibly through oxidative stress-nuclear factor κB-apoptosis pathway. Pharmacol Rep 64 1505-1514, 2012.
21. Huang W, Li G, Qiu J, Gonzalez P and Challa P Protective effects of resveratrol in experimental retinal detachment. PLoS One 8 e75735, 2013.
22. Vin AP, Hu H, Zhai Y, et al Neuroprotective effect of resveratrol prophylaxis on experimental retinal ischemic injury. Exp Eye Res 108 72-75, 2013.
23. Busch F, Mobasheri A, Shayan P, Lueders C, Stahlmann R and Shakibaei M Resveratrol modulates interleukin-1β-induced phosphatidylinositol 3-kinase and nuclear factor κB signaling pathways in human tenocytes. J Biol Chem 287 38050-38063, 2012.
24. Zhang ZX, Wang YS, Shi YY, et al Hypoxia specific SDF-1 expression by retinal pigment epithelium initiates bone marrow-derived cells to participate in Choroidal neovascu-larization in a laser-induced mouse model. Curr Eye Res 36 838-849, 2011.
25. Carbajo-Pescador S, Ordoñez R, Benet M, et al Inhibtion of VEGF expression through blockade of Hif1α and STAT3 signalling mediates the anti-angiogenic effect of melatonin in HepG2 liver cancer cells. Br J Cancer 109 83-91, 2013.
26. Semenza GL HIF-1 and mechanisms of hypoxia sensing. Curr Opin Cell Biol 13 167-171, 2001.
27. Piret JP, Mottet D, Raes M and Michiels C CoCl2V, a chemical inducer of hypoxia-inducible factor-1 and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci 973 443-447, 2002.
28. Jin F, Hagemann N, Schäfer ST, Brockmeier U, Zechariah A and Hermann DM SDF-1 restores angiogenesis synergistically with VEGF upon LDL exposure despite CXCR4 internalization and degradation. Cardiovasc Res 100 481-491, 2013.
29. Sun X, Charbonneau C, Wei L, Yang W, Chen Q and Terek RM CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis. Mol Cancer Ther 12 1163-1170, 2013.
30. Manu KA, Shanmugam MK, Rajendran P, et al Plumbagin inhibits invasion and migration of breast and gastric cancer cells by downregulating the expression of chemokine receptor CXCR4. Mol Cancer 10 107, 2011.
31. Manu KA, Shanmugam MK, Ramachandran L, et al First evidence that ?-tocotrienol inhibits the growth of human gastric cancer and chemosensitizes it to capecitabine in a xenograft mouse model through the modulation of NF-κB pathway. Clin Cancer Res 18 2220-2229, 2012.
32. Shanmugam MK, Manu KA, Ong TH, et al Inhibition of CXCR4/CXCL12 signaling axis by ursolic acid leads to suppression of metastasis in transgenic adenocarcinoma of mouse prostate model. Int J Cancer 129 1552-1563, 2011.
33. Wang G, Chen C, Yang R, et al p55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-κB pathway. Angiogenesis 16 561-573, 2013.
34. Arora S, Bhardwaj A, Singh S, et al An undesired effect of chemotherapy gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4. J Biol Chem 288 21197-21207, 2013.
35. Weekes CD, Song D, Arcaroli J, et al Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancer. Neoplasia 14 690-701, 2012.
36. Kunimasa K, Ohta T, Tani H, et al Resveratrol derivative-rich melinjo (Gnetum gnemon L.) seed extract suppresses multiple angiogenesis-related endothelial cell functions and tumor angiogenesis. Mol Nutr Food Res 55 1730-1734, 2011.
37. Fouad MA, Agha AM, Merzabani MM and Shouman SA Resveratrol inhibits proliferation, angiogenesis and induces apoptosis in colon cancer cells calorie restriction is the force to the cytotoxicity. Hum Exp Toxicol 32 1067-1080, 2013.